PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.46%
Net income growth under 50% of AVGO's 280.95%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.45%
Some D&A expansion while AVGO is negative at -2.50%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-116.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
9.30%
SBC growth of 9.30% while AVGO is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-1385.71%
Both reduce yoy usage, with AVGO at -563.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-260.90%
Both yoy AR lines negative, with AVGO at -112.50%. Martin Whitman would suspect an overall sector lean approach or softer demand.
13.95%
Inventory shrinking or stable vs. AVGO's 55.56%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
317.86%
Some yoy usage while AVGO is negative at -284.21%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-100.00%
Negative yoy while AVGO is 900.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-29.07%
Both yoy CFO lines are negative, with AVGO at -10.87%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
49.77%
CapEx growth well above AVGO's 57.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
28.02%
Purchases growth of 28.02% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
24.03%
Liquidation growth of 24.03% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
92.17%
Investing outflow well above AVGO's 57.14%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-43.18%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.